Index your Journal on RJRIndex — A product by ResearchJournalRank.com Index Now
34,970+ Journals Indexed Journal Suggester  |  Paper Finder  |  Compare Journals
Home › ImmunoTargets and Therapy

ImmunoTargets and Therapy

Q2 Journal Open Access Scopus Active Journal
Country
New Zealand
Pacific Region
Subject Area and Category
Immunology and Microbiology
└ Immunology Q2
└ Immunology and Allergy Q2
SJR 2025
1.110
Q2
SJR Score
H-Index
36
Citations / Doc (2yr)
3.94
Total Docs. (latest)
91
Total Citations (3yr)
324
Publication type
Journals
ISSN
22531556
Coverage
2015-2026
Journal Rank
#4,114
Advertisement

Subject Categories

Immunology Q2
Immunology and Allergy Q2

Aims & Scope

ImmunoTargets and Therapy is an international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered. In addition, the journal will focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. This journal explores the evidence behind new and existing therapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional. As of 1st April 2019, ImmunoTargets and Therapy will no longer consider meta-analyses for publication.

Abstracting & Indexing

Scopus Google Scholar Directory of Open Access Journals (DOAJ) Web of Science Embase

Detailed Metrics

Total Docs. (latest) 91
Total Docs. (3 years) 76
Total Refs. 7,436
Total Citations (3 years) 324
Citable Docs. (3 years) 74
Citations / Doc. (2 years) 3.94
Ref. / Doc. 81.71
% Female 47.4%

Metrics Visualization

Latest year data vs 3-year cumulative figures

Publication & Citation Trend

Loading trend data from Crossref...

Top 10 Most Cited Articles

Loading articles...

Frequently Asked Questions

What is the impact factor of ImmunoTargets and Therapy?

The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, ImmunoTargets and Therapy has an SJR of 1.110 and is ranked Q2.

What is the SJR and quartile of ImmunoTargets and Therapy?

ImmunoTargets and Therapy has an SJR (SCImago Journal Rank) of 1.110 and its best quartile is Q2.

What is the H-index of ImmunoTargets and Therapy?

The H-index of ImmunoTargets and Therapy is 36, meaning 36 of its articles have each been cited at least 36 times.

Is ImmunoTargets and Therapy indexed in Scopus?

Yes. ImmunoTargets and Therapy is active in Scopus (Scopus Source List, August 2026).

Advertisement

Journal Information

SJR1.110
Best QuartileQ2
H Index36
ISSN22531556
PublisherDove Medical Press Ltd
CountryNew Zealand
RegionPacific Region
Coverage2015-2026
Open AccessYes
TypeJournal
Rank#4,114

Similar Journals

View all Immunology and Microbiology journals

Embed This Journal

Add this journal's ranking badge to your website:

<iframe src="https://researchjournalrank.com/widget.php?id=1116" style="border:1px solid #e0e0e0;border-radius:8px;width:100%;max-width:320px;height:200px" frameborder="0"></iframe>
Preview:

Researcher Reviews

Write a Review

No reviews yet for this journal.

Be the first to share your experience!

Share Your Experience

Your review will be published after moderation. Email will not be displayed publicly.

★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★